A History of Cancer Research: Retroviral Insertional Mutagenesis

Joseph Lipsick1

  • 1Departments of Pathology, Genetics, and Biology, Stanford University, Stanford, California 94305-5324, USA lipsick@stanford.edu.

Insights

Retroviruses can cause cancer through insertional mutagenesis, where viral DNA activates cellular proto-oncogenes. This discovery revealed new oncogenes and tumor suppressors, impacting early gene therapy research.

Area of Science:

  • Oncology
  • Virology
  • Molecular Biology

Background:

  • Early cancer research identified oncogenes in some retroviruses promoting tumorigenesis.
  • The mechanism by which oncogene-free retroviruses cause cancer remained unclear.
  • Proto-oncogenes are cellular genes that can promote cancer when aberrantly expressed.

Purpose of the Study:

  • To review the historical discoveries of retroviral insertional mutagenesis in cancer.
  • To explain how viral sequences can activate endogenous proto-oncogenes.
  • To discuss the implications for identifying new oncogenes, tumor suppressors, and gene therapy.

Main Methods:

  • Historical review of scientific literature from the 1980s.
  • Analysis of studies on retroviral mechanisms in cancer development.
  • Examination of the impact on oncogene and tumor suppressor gene discovery.

Main Results:

  • Discovery of insertional mutagenesis as a cancer-causing mechanism for oncogene-free retroviruses.
  • Viral sequences were found to drive aberrant expression of cellular proto-oncogenes.
  • Identification of novel oncogenes and tumor suppressor genes resulted from these studies.

Conclusions:

  • Insertional mutagenesis by retroviruses is a significant mechanism in cancer development.
  • This phenomenon expanded the understanding of oncogenesis and tumor suppression.
  • The findings highlighted risks associated with early gene therapy approaches.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.0K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.3K